PatchSiren cyber security CVE debrief
CVE-2026-64202 NI CVE debrief
AI-assisted PatchSiren debrief based on the supplied source corpus. The CVE record was published on 2026-08-25T17:17:59.447Z and has not been modified since then. The NVD entry is currently Analyzed. Organizations and individuals using NI LabVIEW 2026 Q3 (26.3.0) and prior versions should be aware of this vulnerability and take necessary precautions to prevent exploitation. This includes reviewing system configurations, applying patches, and monitoring system logs for suspicious activity. Security teams should prioritize patching and verify system integrity. IT operators managing NI LabVIEW deployments should validate system exposure and plan for updates through normal change control processes. Vulnerability management teams should assess the risk and implement compensating controls if necessary. Asset inventory and configuration management processes should be reviewed to ensure accurate tracking of affected systems. Change management windows should be scheduled to apply patches with minimal disruption. Source tracking and monitoring should be implemented to detect potential exploitation attempts. Security teams should also conduct regular vulnerability assessments and penetration testing to identify and address potential weaknesses. Additionally, organizations should consider implementing monitoring and detection controls to identify potential exploitation attempts and have incident response plans in place in case of a successful exploit. By taking these precautions, organizations can reduce the risk of exploitation and protect their systems from potential attacks. The CVE record and NVD entry provide details on a memory corruption vulnerability in NI LabVIEW. The vulnerability affects multiple versions of NI LabVIEW, including 2026 Q3 (26.3.0) and prior versions. Evidence is limited to CVE and NVD data. Users should review system configurations and apply patches. Security teams should prioritize patching and verify system integrity. IT operators managing NI LabVIEW deployments should validate system exposure and plan for updates through normal change control processes. Vulnerability management teams should assess the risk and implement compensating controls if
- Vendor
- NI
- Product
- LabVIEW
- CVSS
- HIGH 8.5
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-08-25
- Original CVE updated
- 2026-09-03
- Advisory published
- 2026-08-25
- Advisory updated
- 2026-09-03
Who should care
Organizations and individuals using NI LabVIEW 2026 Q3 (26.3.0) and prior versions should be aware of this vulnerability and take necessary precautions to prevent exploitation. This includes reviewing system configurations, applying patches, and monitoring system logs for suspicious activity. Security teams should prioritize patching and verify system integrity. IT operators managing NI LabVIEW deployments should validate system exposure and plan for updates through normal change control processes. Vulnerability management teams should assess the risk and implement compensating controls if necessary. Asset inventory and configuration management processes should be reviewed to ensure accurate tracking of affected systems. Change management windows should be scheduled to apply patches with minimal disruption. Source tracking and monitoring should be implemented to detect potential exploitation attempts. Security teams should also conduct regular vulnerability assessments and penetration testing to identify and address potential weaknesses. Additionally, organizations should consider implementing monitoring and detection controls to identify potential exploitation attempts and have incident response plans in place in case of a successful exploit. By taking these precautions, organizations can reduce the risk of exploitation and protect their systems from potential attacks. The CVE record and NVD entry provide details on a memory corruption vulnerability in NI LabVIEW. The vulnerability affects multiple versions of NI LabVIEW, including 2026 Q3 (26.3.0) and prior versions. The CVE record was published on 2026-08-25T17:17:59.447Z and has not been modified since then. Evidence is limited to CVE and NVD data. Users should review system configurations and apply patches. Security teams should prioritize patching and verify system integrity. IT operators managing NI LabVIEW deployments should validate system exposure and plan for updates through normal change control processes. Vulnerability management teams should assess the risk and implement compensating controls if necessary. Asset inventory and configuration management processes should be reviewed to ensure accurate
Technical summary
A memory corruption vulnerability exists in NI LabVIEW, which may result in information disclosure or arbitrary code execution. Successful exploitation requires a user to open a specially crafted VI. The vulnerability affects NI LabVIEW 2026 Q3 (26.3.0) and prior versions. Users should review system configurations and apply patches. The vulnerability can be addressed by applying patches or updates provided by the vendor to vulnerable systems, restricting access to sensitive systems or data, monitoring system logs for suspicious activity, implementing compensating controls to reduce the attack surface, and conducting regular vulnerability assessments and penetration testing. Organizations using NI LabVIEW 2026 Q3 (26.3.0) and prior versions should prioritize patching to prevent potential information disclosure or arbitrary code execution. This can be achieved by confirming whether affected product deployments exist in managed environments and assigning an owner for follow-up, reviewing the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance, planning vendor-supported updates or mitigations through normal change control where exposure is confirmed, reviewing compensating controls for exposed systems while remediation is scheduled and verified, checking relevant monitoring, detection, and logs for exposed assets that need extra review, and tracking exceptions, retesting remediated assets, and closing the item only after evidence is documented.
Defensive priority
Organizations using NI LabVIEW 2026 Q3 (26.3.0) and prior versions should prioritize patching to prevent potential information disclosure or arbitrary code execution.
Recommended defensive actions
- Apply patches or updates provided by the vendor to vulnerable systems
- Restrict access to sensitive systems or data
- Monitor system logs for suspicious activity
- Implement compensating controls to reduce the attack surface
- Conduct regular vulnerability assessments and penetration testing
Evidence notes
The CVE record and NVD entry provide details on a memory corruption vulnerability in NI LabVIEW. The vulnerability affects multiple versions of NI LabVIEW, including 2026 Q3 (26.3.0) and prior versions. The CVE record was published on 2026-08-25T17:17:59.447Z and has not been modified since then. Evidence is limited to CVE and NVD data.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-64202 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-64202
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-64202 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-64202
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Source reference
Unverified legacy reference
URL: https://www.ni.com/en/support/security/available-critical-and-security-updates-for-ni-software/2026/memory-corruption-vulnerabilities-ni-labview.html
[email protected] - Patch, Vendor Advisory
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.